Imatinib Mesylate in Treating Patients With Gliomas (Q66036095)

From Wikidata
Jump to navigation Jump to search
clinical trial
edit
Language Label Description Also known as
English
Imatinib Mesylate in Treating Patients With Gliomas
clinical trial

    Statements

    Open Label Phase II Study On STI571 (Glivec) Administered As A Daily Oral Treatment In Gliomas (English)
    0 references
    0 references
    0 references
    0 references
    0 references
    0 references
    0 references
    0 references
    0 references
    March 2002
    0 references
    August 2004
    0 references
    112
    0 references
    18 year
    0 references

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit